Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention

By Lombo Bernardo   Dííez Joséé G  

Future Cardiology, Vol. 7, Iss. 3, 2011-05 ,pp. : 281-285

Future Medicine

Access to resources Recommend Favorite

Bedaquiline: A New Hope for Shorter and Better Anti-Tuberculosis Regimens

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 13, Iss. 1, 2018-04 ,pp. : 3-11

Bentham Science Publishers

Access to resources Recommend Favorite

Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor

By Hara T.   Yokoyama A.   Morishima Y.   Kunitada S.  

Thrombosis Research, Vol. 80, Iss. 1, 1995-10 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Comparative study of the pharmacokinetic profiles of two LMWHs-bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)-administered subcutaneously to healthy male volunteers

By Depasse F.   Gonzalez de Suso M.J.   Lagoutte I.   Fontcuberta J.   Borrell M.   Samama M.M.  

Thrombosis Research, Vol. 109, Iss. 2, 2003-01 ,pp. : 109-117

Elsevier

Access to resources Recommend Favorite

Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series

By Deal Eli  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 188-194

Springer Publishing Company

Access to resources Recommend Favorite